Bleomycin-induced flagellate dermatitis

Keywords: Bleomycin, Hodgkin lymphoma, Flagellate dermatitis Anahtar Sözcükler: Bleomisin, Hodgkin Lenfoma, Flagella dermatit To the Editor, Bleomycin is a cytostatic, antineoplastic antibiotic that is used in both of the first-line treatments of Hodgkin lymphoma: ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) and BEACOPP (doxorubicin, bleomycin, vincristine, cyclophosphamide, etoposide, prednisone, procarbazine). Even though the exact mechanism is not clear, minor skin traumas are thought to be responsible since they increase blood flow to the affected area and cause drug accumulation [1]. Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included. ©Copyright 2019 by Turkish Society of Hematology Turkish Journal of Hematology, Published by Galenos Publishing House Address for Correspondence/Yazışma Adresi: Esra TURAN ERKEK, M.D., Lütfi Kırdar Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey Phone : +90 533 447 85 95 E-mail : dresraturan@gmail.com ORCID-ID: orcid.org/0000-0001-7206-6699 Received/Geliş tarihi: 12 September 12, 2018 Accepted/Kabul tarihi: 2 January 02, 2019 DOI: 10.4274/tjh.galenos.2019.2018.0317 References 1.Diao DY, Goodall J. Bleomycin-induced flagellate dermatitis.